Abstract

Significant and continuous improvement in quantitative chemical shift imaging (QCSI) in patients with Gaucher disease treated with taliglucerase alfa during the early access program

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call